October 2007
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Lebrikizumab 8-Week Maintenance Dosing in Atopic Dermatitis
2
What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata
3
Diabetes Dialogue: The International Diabetes Federation and Care Access in India, With Amit Gupta, MBBS, DNB
4
CT Air Trapping Metric May Predict Post-BLVR Pneumothorax Risk
5